ADMA Biologics, Inc. Financial Ratios — ADMA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-257.84	-93.82	-65.33	-56.99	-70.83	-82.34	-66.45	-66.78	-44.71	-45.25	-29.61	-21.1	-8.33	48.34	26.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-99.06
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.8
Gross Margin (%)	- -	40.16	34.04	36.74	39.93	40.34	-28.14	-148.42	-34.6	-45.17	1.45	22.89	34.44	51.48	57.39
EBITDA Margin (%)	- -	-691.08	-483.5	-266.6	-209.6	-158.15	-157.17	-334.66	-130.04	-144.42	-65.33	-20.93	11.6	34.48	39.11
Operating Margin (%)	- -	-707.36	-490.37	-270.79	-216.14	-162.56	-169	-354.95	-141.14	-153.75	-72.12	-25.55	8.38	32.59	37.53
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	58.57	69.75	62.66
Pretax Margin (%)	- -	-708.24	-506.17	-293.55	-250.36	-183.05	-192.26	-387.06	-164.5	-179.41	-88.52	-42.77	-10.94	29.48	35.8
Profit Margin (%)	- -	-653	-506.17	-284.22	-250.36	-183.05	-192.26	-387.06	-164.5	-179.41	-88.52	-42.77	-10.94	46.35	28.8
Net Income to Common Margin (%)	- -	-653	-506.17	-284.22	-250.36	-183.05	-192.26	-387.06	-164.5	-179.41	-88.52	-42.77	-10.94	46.35	28.8
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.56
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	4	5	15	16	20	43	44	85	98	103	154	141	82	80
ST Debt	- -	- -	- -	- -	- -	6	- -	- -	- -	- -	1	1	1	1	4
LT Debt	- -	4	5	15	16	14	43	44	85	97	102	154	140	81	76
Total Debt/EBITDA	- -	-0.51	-0.34	-0.94	-1.05	-1.2	-1.2	-0.78	-2.22	-1.6	-1.95	-4.79	4.72	0.56	0.4
Net Debt/EBITDA	0.32	1.12	1.43	0.16	-0.35	-0.61	- -	-0.38	-1.48	-0.61	-0.83	-1.75	2.64	-0.21	-0.08
Total Debt/EBIT	- -	-0.5	-0.34	-0.92	-1.01	-1.17	-1.12	-0.73	-2.05	-1.5	-1.76	-3.92	6.54	0.59	0.42
Net Debt/EBIT	0.32	1.09	1.41	0.16	-0.34	-0.59	- -	-0.35	-1.36	-0.57	-0.75	-1.43	3.66	-0.22	-0.08
EBITDA to Interest Expense	- -	-251.84	-23.99	-12.26	-8.16	-7.53	-10.89	-10.29	-4.24	-5.09	-4.05	-1.67	1.2	10.55	28.06
EBITDA-CapEx/Interest Expense	- -	-255.71	-24.31	-14.07	-8.18	-7.56	-11.7	-10.67	-4.67	-6.15	-5.08	-2.39	1	9.94	24.85
EBIT to Interest Expense	- -	-257.77	-24.33	-12.45	-8.42	-7.74	-11.71	-10.92	-4.61	-5.42	-4.47	-2.04	0.86	9.98	26.93
Interest Expense	- -	- -	1	1	2	2	3	6	9	12	13	19	25	14	7
Common Equity/Total Assets	-1,642.46	-238.56	-164.59	-256.99	-368.63	-451.48	-139.5	-243.52	-208.28	-163.94	-149.17	-137.17	-153.79	-63.14	-25.89
Long-Term Debt/Equity (%)	- -	41.99	23.47	245.52	1,914.25	- -	106.54	223.54	322.61	110.26	72.48	101.03	103.82	23.18	15.92
Long-Term Debt/Capital (%)	- -	-11.94	-10.65	-26.98	-21.92	-16.27	-39.89	-25.66	-46.95	-40.08	-33.1	-47.45	-38.48	-35.73	-92.94
Long-Term Debt/Total Assets (%)	- -	25.44	15.83	54.59	66.27	59.58	39.78	49.73	66.49	46.85	37.04	44.06	42.64	16.55	12.17
Total Debt/Equity (%)	- -	42.12	23.53	245.75	1,916.09	-453.7	106.54	223.69	323.48	110.67	72.9	101.62	104.59	23.53	16.74
Total Debt/Capital (%)	- -	-11.98	-10.67	-27	-21.94	-23.32	-39.89	-25.68	-47.08	-40.23	-33.29	-47.73	-38.76	-36.26	-97.73
Total Debt/Total Assets (%)	- -	25.52	15.87	54.64	66.33	85.38	39.78	49.76	66.67	47.03	37.26	44.32	42.96	16.8	12.8
Net Debt to Equity	651.76	-91.85	-98.05	-41.58	638.05	-231.26	-0.34	107.84	215.5	41.98	31.01	37.05	58.61	-8.83	-3.24
Net Debt/Capital (%)	5.74	18.95	28.7	3.48	-6.38	-10.67	0.09	-10.94	-27.3	-12.4	-12.15	-13.73	-19.04	9.35	9.14
EBITDA	- -	-8	-15	-16	-15	-17	-36	-57	-38	-61	-53	-32	30	147	200
EBITDA-CapEx	- -	-8	-15	-18	-15	-17	-38	-59	-42	-74	-66	-46	25	138	177
Operating Income (Loss)	- -	-8	-15	-16	-16	-17	-38	-60	-41	-65	-58	-39	22	139	191

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.87	6.9	7.95	5.21	3.99	1.36	4.57	2.36	1.91	2.8	1.68	2.2	1.03	1.86	1.26
Current Ratio	0.87	7.68	8.49	5.74	5.05	1.93	6.6	4.63	6.12	7.71	6.87	6.89	5.16	5.97	6.71
Quick Ratio	0.87	6.92	7.95	5.3	4.21	1.45	4.98	2.51	2.15	3.47	2.62	2.6	1.58	2.76	3.54
CFO/Avg Current Liab	-2.62	-7.56	-3.98	-3.74	-3.66	-2.37	-3.61	-6.58	-6.44	-6	-4.47	-1.71	0.2	2.25	0.81
Common Equity/Total Assets	-1,642.46	-238.56	-164.59	-256.99	-368.63	-451.48	-139.5	-243.52	-208.28	-163.94	-149.17	-137.17	-153.79	-63.14	-25.89
Long-Term Debt/Equity (%)	- -	41.99	23.47	245.52	1,914.25	- -	106.54	223.54	322.61	110.26	72.48	101.03	103.82	23.18	15.92
Long-Term Debt/Capital (%)	- -	-11.94	-10.65	-26.98	-21.92	-16.27	-39.89	-25.66	-46.95	-40.08	-33.1	-47.45	-38.48	-35.73	-92.94
Long-Term Debt/Total Assets (%)	- -	25.44	15.83	54.59	66.27	59.58	39.78	49.73	66.49	46.85	37.04	44.06	42.64	16.55	12.17
Total Debt/Equity (%)	- -	42.12	23.53	245.75	1,916.09	-453.7	106.54	223.69	323.48	110.67	72.9	101.62	104.59	23.53	16.74
Total Debt/Capital (%)	- -	-11.98	-10.67	-27	-21.94	-23.32	-39.89	-25.68	-47.08	-40.23	-33.29	-47.73	-38.76	-36.26	-97.73
Total Debt/Total Assets (%)	- -	25.52	15.87	54.64	66.33	85.38	39.78	49.76	66.67	47.03	37.26	44.32	42.96	16.8	12.8
CFO/Total Liabilities	-295.38	-112.59	-104.62	-69.97	-67.35	-64.92	-55.07	-90.7	-75.52	-85.41	-83.19	-30.29	4.54	84.97	34.3
CFO/CapEx	- -	-58.09	-55.37	-6.33	-591.36	-248.86	-13.93	-29.91	-19.99	-8.01	-8.32	-4.28	1.77	13.84	2.2
Altman's Z-Score	-33.48	-4.01	0.2	-1.49	-3.95	-6.43	-1.87	-4.51	-1.96	-1.58	-0.88	1.28	2.73	18.79	20

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	57.18	156.86	30.81	10.97	10.98	9.29	6.44	12.07	5.05	3.87	6.99	12.03	11.02	4.9
Days Sales Outstanding	- -	6.38	2.33	11.85	33.27	33.25	39.27	56.65	30.24	72.22	94.28	52.21	30.34	33.13	74.56
Inventory Turnover	- -	1.06	1.38	2.22	1.67	1.5	3.31	2.7	1.1	0.91	0.77	0.83	1.01	1.21	1.15
Days Inventory Outstanding	- -	345.22	264.68	164.72	218.19	242.9	110.44	135.14	331.15	400.78	471.89	442.37	362.46	302.67	316.22
Accounts Payable Turnover	- -	3.65	1.29	1.69	3.13	3.41	8.67	8.15	9.81	8.87	10.46	12.27	12.39	11.38	11.87
Accounts Payable Turnover Days	- -	99.87	283.36	216.6	116.68	107	42.11	44.78	37.2	41.17	34.88	29.76	29.47	32.06	30.75
Cash Conversion Cycle	- -	251.74	-16.35	-40.03	134.77	169.15	107.6	147.01	324.18	431.83	531.28	464.83	363.32	303.74	360.02
Inventory to Cash Days	- -	-338.83	-262.36	-152.88	-184.92	-209.65	-71.16	-78.49	-300.91	-328.56	-377.61	-390.16	-332.12	-269.54	-241.66
Inventories	- -	1	2	2	3	5	13	19	53	82	125	163	173	170	206
Raw Materials	- -	- -	- -	- -	- -	5	10	14	33	32	37	49	53	60	97
Work In Process	- -	- -	- -	- -	- -	- -	1	- -	14	30	59	56	50	62	58
Finished Goods	- -	- -	- -	- -	- -	- -	1	5	5	19	29	58	70	48	52
Other Inventory	- -	1	2	2	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	51	104	84	62	73	108	217	168	197	768	1,012	3,997	4,347
- Cash & Cash Equivalents	- -	13	26	17	10	10	43	23	27	56	51	87	51	103	88
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	4	5	15	16	20	43	44	85	98	103	154	141	82	80
Enterprise Value	- -	-9	27	97	83	67	73	129	275	210	249	836	1,102	3,976	4,339
Total Capital	- -	-33	-48	-55	-72	-87	-108	-172	-180	-243	-309	-324	-365	-226	-82
Total Debt/Capital (%)	- -	-11.98	-10.67	-27	-21.94	-23.32	-39.89	-25.68	-47.08	-40.23	-33.29	-47.73	-38.76	-36.26	-97.73
Total Debt / EV	- -	-0.46	0.19	0.15	0.19	0.3	0.59	0.34	0.31	0.47	0.41	0.18	0.13	0.02	0.02
EV/Sales	- -	- -	8.78	16.35	11.56	6.3	3.22	7.62	9.38	4.97	3.07	5.42	4.27	9.32	8.5
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.79	27.04	21.74
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.96	28.61	22.66
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.59	28.29	77.32
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.41	26.66	54.92
Diluted Market Cap	- -	- -	51	104	84	62	73	108	217	168	197	768	1,012	4,173	4,467
Diluted Enterprise Value	- -	-9	30	101	89	73	73	129	275	210	249	836	1,102	4,152	4,459
EV per Share	- -	- -	4.12	10.41	7.97	5.52	3.2	2.87	5.07	2.43	1.78	4.22	4.92	17.06	18.21
TTM Sales	- -	1	3	6	7	11	23	17	29	42	81	154	258	426	510
TTM EBITDA	- -	-8	-15	-16	-15	-17	-36	-57	-38	-61	-53	-32	30	147	200
TTM Operating Income	- -	-8	-15	-16	-16	-17	-38	-60	-41	-65	-58	-39	22	139	191
TTM Cash Flow to Firm	- -	-7	-10	-13	-14	-16	-34	-57	-67	-90	-99	-40	34	141	56
TTM Free Cash Flow to Firm	- -	-7	-10	-11	-14	-16	-31	-55	-63	-77	-86	-26	39	149	79

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-4.77	-8.38	-5.46	-3.42	-2.12	-1.78	-3	-1.88	-1.99	-16.84	73.46	32.8	60.95
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.96	28.61	22.66
Enterprise Value	- -	-9	27	97	83	67	73	129	275	210	249	836	1,102	3,976	4,339
Low Price	- -	- -	6.52	6.76	7.51	4.15	2.01	2.08	2.34	1.45	1.01	1.26	2.95	4.37	13.5
EV/Sales	- -	- -	8.78	16.35	11.56	6.3	3.22	7.62	9.38	4.97	3.07	5.42	4.27	9.32	8.5
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.79	27.04	21.74
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.22	29.58
Price/Earnings Average	- -	- -	-3.33	-5.29	-5.35	-3.87	-1.97	-3.39	-4.65	-3.17	-3.28	-6.78	-29.18	14.32	29.05
Price/Earnings High	- -	- -	-3.75	-7.74	-6.92	-5.51	-3.03	-4.78	-7.1	-5.29	-6.06	-11.77	-36.88	27.87	41.63
Price/Earnings Low	- -	- -	-2.74	-3.74	-4.35	-2.58	-1.05	-1.43	-2.63	-1.65	-1.97	-3.78	-23.4	5.15	21.9
Price/Book Value	- -	- -	-0.97	-1.49	-0.96	-0.58	-0.49	-0.5	-0.82	-0.49	-0.48	-1.61	-2	-12.96	-26.89
Price/Book Value Average	- -	- -	-0.98	-1.28	-1.1	-0.71	-0.57	-1.03	-0.85	-0.71	-0.57	-0.93	-1.63	-9.18	-26.41
Price/Book Value High	- -	- -	-1.11	-1.87	-1.42	-1.01	-0.88	-1.45	-1.3	-1.18	-1.05	-1.62	-2.06	-17.86	-37.85
Price/Book Value Low	- -	- -	-0.81	-0.9	-0.89	-0.47	-0.31	-0.43	-0.48	-0.37	-0.34	-0.52	-1.31	-3.3	-19.9
Price/Tangible Book Value	- -	- -	2.36	17.27	102.35	-13.96	2.3	8.83	11.15	2.04	1.45	5.21	7.72	11.59	9.19
Price/Tangible Book Value Average	- -	- -	2.39	14.8	117.14	-16.93	2.7	18.19	11.5	2.92	1.73	3.03	6.28	8.21	9.02
Price/Tangible Book Value High	- -	- -	2.7	21.65	151.56	-24.13	4.15	25.7	17.58	4.87	3.19	5.26	7.94	15.97	12.93
Price/Tangible Book Value Low	- -	- -	1.97	10.45	95.25	-11.32	1.44	7.68	6.52	1.52	1.04	1.69	5.04	2.95	6.8
Price/Sales	- -	- -	16.61	17.55	11.71	5.84	3.23	6.36	7.41	3.98	2.43	4.98	3.92	9.37	8.52
Price/Sales Average	- -	- -	16.83	15.04	13.4	7.08	3.79	13.1	7.64	5.69	2.9	2.9	3.19	6.64	8.37
Price/Sales High	- -	- -	18.97	21.99	17.34	10.09	5.82	18.52	11.68	9.49	5.36	5.03	4.03	12.92	11.99
Price/Sales Low	- -	- -	13.88	10.62	10.89	4.73	2.02	5.53	4.33	2.96	1.74	1.62	2.56	2.39	6.31
Price/Cash Flow	- -	- -	-4.68	-7.06	-5.45	-3.41	-1.97	-1.72	-2.85	-1.65	-1.75	-12.9	115.04	33.68	86.25
Price/Cash Flow Average	- -	- -	-4.74	-6.05	-6.24	-4.13	-2.31	-3.55	-2.94	-2.35	-2.09	-7.51	93.63	23.86	84.69
Price/Cash Flow High	- -	- -	-5.34	-8.85	-8.07	-5.89	-3.56	-5.02	-4.5	-3.93	-3.86	-13.03	118.35	46.43	121.38
Price/Cash Flow Low	- -	- -	-3.91	-4.27	-5.07	-2.76	-1.23	-1.5	-1.67	-1.22	-1.25	-4.19	75.08	8.58	63.84
Price/Free Cash Flow Average	- -	- -	-4.83	-7.18	-6.25	-4.15	-2.49	-3.67	-3.1	-2.69	-2.38	-9.8	59.79	23.23	59.85
Price/Free Cash Flow High	- -	- -	-5.44	-10.51	-8.08	-5.91	-3.83	-5.19	-4.74	-4.49	-4.39	-17.01	75.57	45.21	85.78
Price/Free Cash Flow Low	- -	- -	-3.98	-5.07	-5.08	-2.77	-1.33	-1.55	-1.76	-1.4	-1.43	-5.47	47.95	8.36	45.11
EV/Sales Average	- -	- -	9.96	14.62	14.14	8.04	3.78	14.37	9.62	6.68	3.54	3.34	3.54	6.59	8.35
EV/Sales High	- -	- -	12.1	21.58	18.07	11.06	5.82	19.78	13.66	10.48	6	5.48	4.38	12.87	11.98
EV/Sales Low	- -	- -	7.01	10.21	11.63	5.7	2.02	6.8	6.31	3.95	2.38	2.06	2.91	2.34	6.29
EV/EBITDA Average	0.32	1.11	-2.06	-5.49	-6.74	-5.09	-2.41	-4.29	-7.4	-4.62	-5.42	-15.95	30.5	19.11	21.35
EV/EBITDA High	0.32	1.11	-2.5	-8.09	-8.62	-6.99	-3.7	-5.91	-10.5	-7.25	-9.19	-26.16	37.76	37.33	30.62
EV/EBITDA Low	0.32	1.11	-1.45	-3.83	-5.55	-3.6	-1.28	-2.03	-4.85	-2.73	-3.65	-9.84	25.06	6.78	16.08
EV/EBIT Average	0.32	1.08	-2.03	-5.4	-6.54	-4.95	-2.24	-4.05	-6.81	-4.34	-4.91	-13.07	42.25	20.22	22.25
EV/EBIT High	0.32	1.08	-2.47	-7.97	-8.36	-6.8	-3.44	-5.57	-9.68	-6.81	-8.32	-21.43	52.31	39.49	31.91
EV/EBIT Low	0.32	1.08	-1.43	-3.77	-5.38	-3.51	-1.19	-1.92	-4.47	-2.57	-3.3	-8.06	34.71	7.18	16.76
Last Price	- -	- -	7.8	11.17	8.07	5.12	3.21	2.39	4	1.95	1.41	3.88	4.52	17.15	18.24
High Price	- -	- -	8.91	14	11.95	8.85	5.79	6.96	6.31	4.65	3.11	3.92	4.65	23.64	25.67
Enterprise Value Average	- -	-9	31	87	101	86	86	244	282	282	287	515	914	2,810	4,260
Enterprise Value High	- -	-9	37	128	130	118	132	336	401	442	486	844	1,132	5,489	6,109
Enterprise Value Low	- -	-9	22	60	83	61	46	115	185	167	193	317	751	998	3,209

Shares Outstanding	9	9	9	9	11	13	45	46	59	105	196	222	226	237	238
Diluted Weighted Avg Shares	2	5	7	9	10	12	23	45	54	86	140	198	224	243	245
Basic Weighted Avg Shares	2	5	7	9	10	12	23	45	54	86	140	198	224	233	238
Revenue per Share	- -	0.24	0.47	0.64	0.69	0.88	0.99	0.38	0.54	0.49	0.58	0.78	1.15	1.83	2.14
EBITDA per Share	-0.01	-1.66	-2.27	-1.7	-1.44	-1.39	-1.56	-1.26	-0.7	-0.71	-0.38	-0.16	0.13	0.63	0.84
Operating Income per Share	-0.01	-1.7	-2.3	-1.72	-1.49	-1.43	-1.68	-1.33	-0.76	-0.75	-0.42	-0.2	0.1	0.6	0.8
Basic EPS, GAAP	-0.01	-1.57	-2.38	-1.81	-1.73	-1.61	-1.91	-1.45	-0.89	-0.88	-0.51	-0.33	-0.13	0.85	0.62
Basic EPS from Cont Ops	-0.01	-1.57	-2.38	-1.81	-1.73	-1.61	-1.91	-1.45	-0.89	-0.88	-0.51	-0.33	-0.13	0.85	0.62
Diluted EPS, GAAP	-0.01	-1.57	-2.38	-1.81	-1.73	-1.61	-1.91	-1.45	-0.89	-0.88	-0.51	-0.33	-0.13	0.81	0.6
Diluted EPS from Cont Ops	-0.01	-1.57	-2.38	-1.81	-1.73	-1.61	-1.91	-1.45	-0.89	-0.88	-0.51	-0.33	-0.13	0.81	0.6
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.01	-1.48	-1.67	-1.58	-1.48	-1.5	-1.63	-1.39	-1.4	-1.18	-0.81	-0.3	0.04	0.51	0.21
Free Cash Flow per Basic Share	-0.01	-1.51	-1.7	-1.83	-1.48	-1.51	-1.74	-1.43	-1.47	-1.33	-0.9	-0.37	0.02	0.47	0.12
Cash & Equivalents per Share	- -	2.69	4.45	2.35	1.61	1.26	1.88	0.5	0.49	0.65	0.37	0.44	0.23	0.44	0.37
Book Value per Share	-0.06	-7.97	-8.06	-7.47	-8.4	-8.8	-6.58	-4.79	-4.87	-3.95	-2.95	-2.42	-2.26	-1.32	-0.68
Tangible Book Value per Share	- -	2.02	3.3	0.65	0.08	-0.37	1.4	0.27	0.36	0.96	0.97	0.75	0.59	1.48	1.99

ADMA Biologics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)